HBsAg escape mutation category | Mutation pattern | Patient, n (%) | Combined pattern | Patient, n (%) |
---|---|---|---|---|
HBIg escape | sP120T, sQ129H, sM133I, sY134N, sD144E, sC147S | 7 (6.48) | sM133I + sD144E | 1 (0.92) |
Vaccine escape | sP120S, sQ129H, sS143L, sD144E, sC147S, sS193L | 9 (8.34) | sT126S + sS193L | 1 (0.92) |
HBsAg misdiagnosis | sP120T, sP120S, sR122K, sT131I, sM133I, sC147S | 10 (9.25) | – | – |
Immune escape | sQ101H, sG119R, sP120T, sT123N, sT131N, sY134F, sD144E | 9 (8.34) | sG119R + sT123N | 1 (0.92) |
Total* | – | 17 (15.74) | – | 3 (2.78) |
Mutation characteristic | Mutation pattern | Nucleos(t)ide analogue | Patient, n (%) |
---|---|---|---|
Primary resistance mutation | rtM204I | LAM, LDT, L-FMAU, FTC | 2 (1.85) |
rtI233V | ADV | 1 (0.92) | |
Total* | – | – | 3 (2.78) |
Partial resistance mutation | rtL80I | LAM, LDT | 1 (0.92) |
rtL180M | LAM, LDT, L–FMAU, FTC | 2 (1.85) | |
Total* | – | – | 3 (2.78) |
Compensatory mutation | rtL91I | LDT | 7 (6.48) |
rtQ149K | ADV | 7 (6.48) | |
rtV214A | LAM, L-FMAU, FTC, TDF | 2 (1.85) | |
rtQ215H/P/S | LAM, L-FMAU, FTC, TDF | 18 (16.67) | |
rtN238D | ADV | 6 (5.56) | |
Total* | – | – | 29 (26.85) |
ADAPVEM | rtM204I/sW196L | LAM, LDT | 2 (1.85) |
Total* | – | – | 2 (1.85) |
HBV genotype | HBV subgenotype | Patients, n (%) | HBsAg serotype, n (%)* | Nationality |
---|---|---|---|---|
D | D1 | 106 (98) | TR, TRNC | |
D2 | 1 (1) | TRNC | ||
E | – | 1 (1) | – | TR |
Total | – | 108 (100) | 97 (100) | – |
Characteristics | Patient group | Study group |
---|---|---|
Patients, n | 170 | 108 |
Gender, M/F, n (%) | 106 (63) / 64 (37) | 68 (63) / 40 (37) |
Age, years (mean ± SD) | 49 ± 31 | 41.5 ± 23.5 |
Nationality Turkish | 122 (71) | 83 (77) |
Turkish Cypriot | 48 (29) | 25 (23) |
HBsAg value, S/Co* (mean ± SD) | 3882.5 ± 3712.5 | 3882.5 ± 3712.5 |